- Home
- STRO vs REFI Comparison
STRO vs REFI Comparison
Compare STRO & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | REFI |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | United States | United States |
| Employees | 131 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 255.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | STRO | REFI |
|---|---|---|
| Price | $24.95 | $10.90 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.38 | N/A |
| AVG Volume (30 Days) | 170.2K | ★ 176.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 17.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | N/A | $15.98 |
| Revenue Next Year | $13.45 | $1.33 |
| P/E Ratio | ★ N/A | $6.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $10.99 |
| 52 Week High | $27.96 | $15.20 |
Technical Indicators
Market Signals| Indicator | STRO | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | 27.52 |
| Support Level | $0.76 | N/A |
| Resistance Level | $27.96 | $12.59 |
| Average True Range (ATR) | 2.09 | 0.33 |
| MACD | -0.06 | -0.14 |
| Stochastic Oscillator | 78.23 | 10.64 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.